Training in vaccine research: vaccine against peptic ulcer

Projektinformationen

ULCERVAC

ID Finanzhilfevereinbarung: QLK4-CT-1999-50407

Projekt abgeschlossen

Startdatum 1 September 2001

Enddatum 31 August 2005

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 211 596,00

EU-Beitrag € 211 596,00

Koordiniert durch

CHIRON S.R.L.
Italy

Ziel

The development of innovative vaccines based on well characterized recombinant antigens. Training in bacterial pathogenesis, molecular genetics, cell biology and immunology.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › genetics
• natural sciences › biological sciences › molecular biology › molecular genetics
• natural sciences › biological sciences › cell biology
• medical and health sciences › basic medicine › immunology
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-4. - Key action Environment and Health

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

CHIRON S.R.L.

• EU-Beitrag: Keine Daten
• Adresse: Via Fiorentina 1 IRIS Research Centre ; 53100 SIENA ; Italien
• Gesamtkosten: Keine Daten